The US Senate report on Thursday presented an interim report on the origins of SARS-CoV-2. Richard Burr, the panel ranking member said he hopes that this repo
India will witness a peak in the number of COVID-19 cases by next month with the expectation of reporting five lakh cases per day, a US-based health expert said
Pfizer says its time for booster dose, US govt says not yet
ANI
09 Jul 2021, 15:37 GMT+10
By Shalini BhardwajWashington [US], July 9 (ANI): US drugmaker Pfizer and Germany s BioNTech have announced that they will seek regulatory authorisation for a third dose of their Covid-19 vaccine.
The companies, whose Covid-19 vaccine is sold under the brand name Comirnaty , are developing a booster shot intended to target the delta variant as concerns rise about the highly transmissible strain.
The companies said they believe a third dose of the mRNA vaccine has the potential to preserve the highest levels of protective efficacy against all currently known variants including Delta.
A ubstantial number of vaccine doses will be sent to India under the US strategy for global vaccine sharing program, said Gayle E Smith, the US State Departm